Pulmonary fibrosis: Emerging targets and novel therapeutics
Yucen Sun, Li Li · 2026
Read Pulmonary fibrosis: Emerging targets and novel therapeutics by Yucen Sun, Li Li (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13269959.txt.
Description
Yucen Sun and Li Li published a review in 2026 on pulmonary fibrosis, a progressive scarring of the lungs that limits breathing and is often fatal. The idiopathic form has no known cause and few effective cures. The review surveys new molecular targets and treatments, including stem cell therapy and inhaled nanomaterials.
For each approach, the authors weigh how it works, what animal and lab evidence supports it, and what clinical promise it holds. They also flag translation problems, such as weak animal models and wide differences between patients. The review is explicitly not systematic, so its selection of studies may be biased. Its findings, the authors warn, should be read with caution.
Catalog record
| CREATOR | Yucen Sun, Li Li |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 31323 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |